Search Results: Displaying all items (1304)

First Author Title Journal Publication Date
González-Moreno J. IGRA testing in patients with immune-mediated inflammatory diseases: which factors influence the results? Rheumatology international 2017
Liu Q. Performance of interferon-γ release assay in the diagnosis of tuberculous lymphadenitis: a meta-analysis. PeerJ 2017
Narasimhan P. High rates of latent TB infection in contacts and the wider community in South India. Transactions of the Royal Society of Tropical Medicine and Hygiene 2017
Feng JY. Impact of Euro-American sublineages of Mycobacterium tuberculosis on new infections among named contacts. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2017
Jeon Y. Diagnostic Utility of New Equation for Active Tuberculosis Based on Parameters of Interferon-γ Release Assay. Laboratory medicine 2017
Balkhy HH. Prevalence of Latent Mycobacterium Tuberculosis Infection (LTBI) in Saudi Arabia; Population based survey. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2017
Ruhwald M. Introducing the ESAT-6 free IGRA, a companion diagnostic for TB vaccines based on ESAT-6. Scientific reports 2017
Zhang H. A dose-response relationship of smoking with tuberculosis infection: A cross-sectional study among 21008 rural residents in China. PloS one 2017
Tanabe M. The Direct Comparison of Two Interferon-gamma Release Assays in the Tuberculosis Screening of Japanese Healthcare Workers. Internal medicine (Tokyo, Japan) 2017
Belliere J. QuantiFERON test interpretation in patients receiving immunosuppressive agents: an alert. The European respiratory journal 2017
Khawcharoenporn T. QuantiFERON(®)-TB Gold In-tube Test for tuberculosis prevention in HIV-infected patients. Japanese journal of infectious diseases 2017
Ota M. Risk of tuberculosis among air passengers estimated by interferon gamma release assay: survey of contact investigations, Japan, 2012 to 2015. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 2017
De Groote MA. Correction for De Groote et al., Journal of clinical microbiology 2017
Ishikawa S. Comparison of interferon-γ release assays, QuantiFERON TB-GIT and T-Spot.TB, in renal transplantation. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2017
Suárez I. Repurposing QuantiFERON for detection of neutralizing IFN-γ autoantibodies in patients with nontuberculous mycobacterial infections. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017
Moon HW. Evaluation of QuantiFERON®-TB Gold-Plus in Healthcare Workers in a Low-Incidence Setting. Journal of clinical microbiology 2017
Auguste P. Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis. BMC infectious diseases 2017
Chang PC. Use of the QuantiFERON-TB Gold In-Tube Test in the Diagnosis and Monitoring of Treatment Efficacy in Active Pulmonary Tuberculosis. International journal of environmental research and public health 2017
Ayubi E. Comparison of QuantiFERON-TB Gold In-Tube (QFT-GIT) and tuberculin skin test (TST) for diagnosis of latent tuberculosis in haemodialysis (HD) patients: a meta-analysis of κ estimates. Epidemiology and infection 2017
Edathodu J. Diagnostic potential of interferon-gamma release assay to detect latent tuberculosis infection in kidney transplant recipients. Transplant infectious disease : an official journal of the Transplantation Society 2017
Load More Results